Deshpande, D., Srivastava, S., Meek, C., Leff, R., Hall, G. S., & Gumbo, T. (2010). Moxifloxacin Pharmacokinetics/Pharmacodynamics and Optimal Dose and Susceptibility Breakpoint Identification for Treatment of Disseminated Mycobacterium avium Infection. American Society for Microbiology (ASM).
استشهاد بنمط شيكاغوDeshpande, Devyani, Shashikant Srivastava, Claudia Meek, Richard Leff, Gerri S. Hall, و Tawanda Gumbo. Moxifloxacin Pharmacokinetics/Pharmacodynamics and Optimal Dose and Susceptibility Breakpoint Identification for Treatment of Disseminated Mycobacterium Avium Infection. American Society for Microbiology (ASM), 2010.
MLA استشهادDeshpande, Devyani, et al. Moxifloxacin Pharmacokinetics/Pharmacodynamics and Optimal Dose and Susceptibility Breakpoint Identification for Treatment of Disseminated Mycobacterium Avium Infection. American Society for Microbiology (ASM), 2010.